Cargando…
Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022
Both tuberculosis (TB) and COVID-19 can affect the respiratory system, and early findings suggest co-occurrence of these infectious diseases can result in elevated mortality. A retrospective cohort of patients who were diagnosed with TB and COVID-19 concurrently (within 120 days) between March 2020...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132536/ https://www.ncbi.nlm.nih.gov/pubmed/37186110 http://dx.doi.org/10.1371/journal.pgph.0001758 |
_version_ | 1785031402085941248 |
---|---|
author | Easton, Alice V. Salerno, Marco M Trieu, Lisa Humphrey, Erica Kaba, Fanta Macaraig, Michelle Dworkin, Felicia Nilsen, Diana M. Burzynski, Joseph |
author_facet | Easton, Alice V. Salerno, Marco M Trieu, Lisa Humphrey, Erica Kaba, Fanta Macaraig, Michelle Dworkin, Felicia Nilsen, Diana M. Burzynski, Joseph |
author_sort | Easton, Alice V. |
collection | PubMed |
description | Both tuberculosis (TB) and COVID-19 can affect the respiratory system, and early findings suggest co-occurrence of these infectious diseases can result in elevated mortality. A retrospective cohort of patients who were diagnosed with TB and COVID-19 concurrently (within 120 days) between March 2020 and June 2022 in New York City (NYC) was identified. This cohort was compared with a cohort of patients diagnosed with TB-alone during the same period in terms of demographic information, clinical characteristics, and mortality. Cox proportional hazards regression was used to compare mortality between patient cohorts. One hundred and six patients with concurrent TB/COVID-19 were identified and compared with 902 patients with TB-alone. These two cohorts of patients were largely demographically and clinically similar. However, mortality was higher among patients with concurrent TB/COVID-19 in comparison to patients with TB-alone, even after controlling for age and sex (hazard ratio 2.62, 95% Confidence Interval 1.66–4.13). Nearly one in three (22/70, 31%) patients with concurrent TB/COVID-19 aged 45 and above died during the study period. These results suggest that TB patients with concurrent COVID-19 were at high risk for mortality. It is important that, as a high-risk group, patients with TB are prioritized for resources to quickly diagnose and treat COVID-19, and provided with tools and information to protect themselves from COVID-19. |
format | Online Article Text |
id | pubmed-10132536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-101325362023-04-27 Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022 Easton, Alice V. Salerno, Marco M Trieu, Lisa Humphrey, Erica Kaba, Fanta Macaraig, Michelle Dworkin, Felicia Nilsen, Diana M. Burzynski, Joseph PLOS Glob Public Health Research Article Both tuberculosis (TB) and COVID-19 can affect the respiratory system, and early findings suggest co-occurrence of these infectious diseases can result in elevated mortality. A retrospective cohort of patients who were diagnosed with TB and COVID-19 concurrently (within 120 days) between March 2020 and June 2022 in New York City (NYC) was identified. This cohort was compared with a cohort of patients diagnosed with TB-alone during the same period in terms of demographic information, clinical characteristics, and mortality. Cox proportional hazards regression was used to compare mortality between patient cohorts. One hundred and six patients with concurrent TB/COVID-19 were identified and compared with 902 patients with TB-alone. These two cohorts of patients were largely demographically and clinically similar. However, mortality was higher among patients with concurrent TB/COVID-19 in comparison to patients with TB-alone, even after controlling for age and sex (hazard ratio 2.62, 95% Confidence Interval 1.66–4.13). Nearly one in three (22/70, 31%) patients with concurrent TB/COVID-19 aged 45 and above died during the study period. These results suggest that TB patients with concurrent COVID-19 were at high risk for mortality. It is important that, as a high-risk group, patients with TB are prioritized for resources to quickly diagnose and treat COVID-19, and provided with tools and information to protect themselves from COVID-19. Public Library of Science 2023-04-26 /pmc/articles/PMC10132536/ /pubmed/37186110 http://dx.doi.org/10.1371/journal.pgph.0001758 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Easton, Alice V. Salerno, Marco M Trieu, Lisa Humphrey, Erica Kaba, Fanta Macaraig, Michelle Dworkin, Felicia Nilsen, Diana M. Burzynski, Joseph Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022 |
title | Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022 |
title_full | Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022 |
title_fullStr | Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022 |
title_full_unstemmed | Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022 |
title_short | Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022 |
title_sort | cohort study of the mortality among patients in new york city with tuberculosis and covid-19, march 2020 to june 2022 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132536/ https://www.ncbi.nlm.nih.gov/pubmed/37186110 http://dx.doi.org/10.1371/journal.pgph.0001758 |
work_keys_str_mv | AT eastonalicev cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT salernomarcom cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT trieulisa cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT humphreyerica cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT kabafanta cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT macaraigmichelle cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT dworkinfelicia cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT nilsendianam cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 AT burzynskijoseph cohortstudyofthemortalityamongpatientsinnewyorkcitywithtuberculosisandcovid19march2020tojune2022 |